✦ LIBER ✦

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

✍ Scribed by Leist, Thomas P; Comi, Giancarlo; Cree, Bruce A C; Coyle, Patricia K; Freedman, Mark S; Hartung, Hans-Peter; Vermersch, Patrick; Casset-Semanaz, Florence; Scaramozza, Matthew

Book ID: 122333637
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 334 KB
Volume: 13
Category: Article
ISSN: 1474-4465
DOI: 10.1016/S1474-4422(14)70005-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of glatiramer acetate on conversi

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

✍ G Comi; V Martinelli; M Rodegher; L Moiola; O Bajenaru; A Carra; I Elovaara; F F 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 180 KB

Effect of early interferon beta-1a thera

Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event

✍ H. Pakdaman; M. A. Sahraian; A. Fallah; R. Pakdaman; K. Ghareghozli; M. Ghafarpo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

Comparison of two dosing frequencies of

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

✍ Giancarlo Comi; Nicola De Stefano; Mark S Freedman; Frederik Barkhof; Chris H Po 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 224 KB